Myanmar receives 30,000 Remdesivir drugs used in COVID-19 treatment from NSIC

KAT 00251 NS
The MoHS Union Minister is receiving Remdesivir for the treatment of COVID-19 from the donor National Strategic Investment Corporation Co. Ltd (NSIC) at Nay Pyi Taw Airport on 20 July 2021.

A Tatmadaw aircraft landed at Nay Pyi Taw Airport, carrying 30,000 Remdesivir drugs donated by the National Strategic Investment Corporation Co. Ltd (NSIC) to the State Administration Council from Hyderabad, India, yesterday evening.
Union Minister for Health and Sports Dr Thet Khaing Win received the donated drugs from the General Manager of NSIC at the airport.
The Remdesivir drugs are used for emergency treatment of COVID-19. It is the most effective medicine to reduce the death toll from the highly contagious COVID-19 virus worldwide. It was developed by Gileat Sciences Inc. in the United States of America and is FDA-approved in the US and Europe.In addition, Hetero Labs Limited from India has purchased a production licence from Gileat Sciences Inc, to manufacture and distribute Remdesivir in developing countries. NSIC ordered 30,000 drugs worth 3 billion kyats from India and donated them to the people of Myanmar through the State Administration Council.—MNA

Share this post
Hot News
Hot News
23 September 2021
Start preparations to harvest short-term species of monsoon paddy
Myanmar to play Singapore in ASEAN Suzuki Cup opener
Myanmar ships over 2.2 mln tonnes of corn to international trade partners this FY
Muse border trade down by 24% as of 10 Sept
Myanmar’s bilateral trade with Germany reaches $460 mln in past ten months
16 acres of avocado cultivation completed in Naga area this year
Pansodan-Dala ferries increase service routes for convenience of passengers
Over 600 acres of coffee cultivated in Sagaing Region
Extremists arrested for explosive actions in Hline Township, Yangon Region